Immediate Impact

38 standout
Sub-graph 1 of 17

Citing Papers

[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients
2023 Standout
2 intermediate papers

Works of D. Gregory being referenced

Electronic Estimations of Renal Function Are Inaccurate in Solid-Organ Transplant Recipients and Can Result in Significant Underdosing of Prophylactic Valganciclovir
2013
Should extrapulmonary small cell cancer be managed like small cell lung cancer?
2010

Author Peers

Author Last Decade Papers Cites
D. Gregory 87 157 169 12 346
Alison Stillie 68 220 170 15 338
L. Gogou 64 126 127 13 406
T. Gadalla 157 135 59 7 382
Carlo Villano 64 106 86 15 322
Khaldoun Kerrou 107 117 76 21 410
Chad G. Rusthoven 156 92 62 18 346
C Lévy-Piedbois 98 77 106 14 398
H. Kolesnikov-Gauthier 74 127 49 18 376
J. Glees 116 147 106 11 390
Hiroko Arimoto 135 108 100 18 348

All Works

Loading papers...

Rankless by CCL
2026